Tempus AI Oncology Platform
Save to shortlistCovers: treatment selection, care-gap identification, clinical trial matching
Last reviewed Oct 31, 2026 against the sources listed on this page · How we review
At a glance
The Tempus AI oncology platform integrates genomic sequencing, clinical records, imaging, and outcomes data into AI-driven tools (e.g., Tempus Next, ALGOS, and the 'David' generative AI clinical…
- FDA:
- Not on record
- Epic:
- Not on record
- Named users:
- 1 named in public reports
- Published study:
- Not on record
Description
The Tempus AI oncology platform integrates genomic sequencing, clinical records, imaging, and outcomes data into AI-driven tools (e.g., Tempus Next, ALGOS, and the 'David' generative AI clinical co-pilot) that support treatment selection, care-gap identification, and clinical trial matching. It connects with thousands of U.S. hospitals and academic medical centers and offers molecular diagnostics including tumor-informed MRD testing. Tempus went public on Nasdaq (TEM) in 2024 and acquired the digital pathology firm Paige.
Quick answers
Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review
- Which health systems use Tempus AI Oncology Platform?
- Linked public reports name one organization: Keck Medicine of USC. "Who's using this" below lists them all, plus any the maker reports. Ask the vendor for a reference at an organization like yours.Keck Medicine of USC (Yahoo Finance)
Security & contracting
The maker has not reported these details yet. Ask the vendor directly during evaluation.
- Workflow stage
- Not reported
- Integrations
- Not reported
- Data inputs
- Not reported
- Deployment
- Not reported
- Signs a BAA
- Not reported
- SOC 2 report
- Not reported
- HITRUST
- Not reported
- Evidence type
- Not assessed
Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.
Who's using this
4 organizationsOrganizations named in public announcements or by the developer. Inclusion is not an endorsement.
Reported by the developer
Last checked Oct 31, 2026. Spot an error? Let us know through the discussion below.
Get weekly updates for Oncology
Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.
Sources
This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.
WebsiteHistory (2)Show
Dated events on this listing's public record, newest first.
- Sep 13, 2026
Added to CIFoundry
- May 1, 2026
News report names Keck Medicine of USC as a user (Yahoo Finance)source
Developer
Tempus AI
Tempus AI, Inc.
Evaluating this tool?
Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.
Prepare evaluation packetChecklist for your role: Admin · Physician · IT · Compliance
Compare similar tools →